Oral Immunostimulant Market Outlook:
Oral Immunostimulant Market size was over USD 22.51 billion in 2025 and is anticipated to cross USD 33.97 billion by 2035, growing at more than 4.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of oral immunostimulant is assessed at USD 23.36 billion.
In the year 2023, the industry size of the oral immunostimulant was USD 23 Billion, which is attributed to the rising cases of chronic diseases like cancer, and cardiovascular diseases which weaken the immune system.
According to a recent report, there were almost 17.8 million deaths in 2019 due to cardiovascular diseases worldwide. Furthermore, the role of oral immunostimulants is crucial in bolstering the immune system which leads to stimulating the market.
In addition, there is a growing demand for oral immunostimulants globally as patients seek comfortable treatment options over other forms of treatment. Oral Immunostimulant is a convenient option for patients as it can be taken in pill or liquid form. Moreover, oral immunostimulant reduces the possible infections and other complications among patients which further boosts the growth of the market.
